Geriatrics
Evidence-Based Reviews
Resilience and mind-body interventions in late-life depression
THIRD OF 4 PARTS
Enhancing resilience can improve outcomes in patients with late-life depression.
From the Journals
Nutrition for cognition: A missed opportunity in U.S. seniors?
Those who didn’t use the SNAP program experienced 2 more years of cognitive aging compared with program users.
From the Journals
Novel drug eases Parkinson’s-related constipation in early trial
The drug, ENT-01, targets abnormal clumps of alpha-synuclein that are a hallmark of Parkinson’s disease.
Opinion
How can I keep from losing my mind?
“To date the actual therapies for dementia have been disappointing.”
From the Journals
Suicide notes offer ‘unique window’ into motives, risks in the elderly
Most previous studies of late-life suicide have focused on risk factors rather than the themes and meaning underlying individuals’ distress.
Latest News
Positive top-line phase 3 data for lecanemab in early Alzheimer’s
“For people in the earliest stages of Alzheimer’s, this treatment has the potential to change the course of the disease in a clinically meaningful...
From the Journals
Urgent need for research into psychedelic therapy for older adults
Little is known about appropriate dosing, pharmacokinetics, and pharmacodynamics of psychedelics in older adults.
From the Journals
Yoga, CBT provide long-term improvement in insomnia, worry
“So to find something they can do that lasts ... and has some enduring impact on their quality of life and their mental health, and they’re both...
Conference Coverage
Sacubitril/valsartan shows cognitive safety in heart failure: PERSPECTIVE
Patients with heart failure on sacubitril/valsartan had no signal of cognitive decline, compared with controls in PERSPECTIVE, a prospective,...
From the Journals
Early dementia but no specialists: Reinforcements needed?
Patients in rural areas are less likely undergo neuropsychological testing.
Commentary
Understanding the relationship between life satisfaction and cognitive decline
Clinical science can profit from exploring cognitive-behavioral therapies to improve adults’ cognitive function or life satisfaction.